CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
12.50
-2.46 (-16.44%)
At close: Jun 27, 2025, 4:00 PM
12.58
+0.08 (0.64%)
After-hours: Jun 27, 2025, 6:21 PM EDT
CorMedix Market Cap
CorMedix has a market cap or net worth of $847.81 million as of June 27, 2025. Its market cap has increased by 203.11% in one year.
Market Cap
847.81M
Enterprise Value
767.39M
1-Year Change
203.11%
Ranking
Category
Stock Price
$12.50
Market Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $847.81M, an increase of 2,378.97%. That is a compound annual growth rate of 23.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 1.01B | 106.45% |
| Dec 31, 2024 | 491.50M | 138.48% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |